Could a Half-Dose of steroids protect preterm Babies' brains just as well?
NCT ID NCT04021485
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 643 children who were born before 32 weeks of pregnancy and whose mothers received either a full or half dose of betamethasone before birth. Researchers will test the children's thinking skills, memory, and social behavior at age 5 to see if the lower dose is just as safe for brain development. The goal is to find out whether reducing steroid exposure can still protect the brain while avoiding unnecessary high doses.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- betamethasone (half-dose vs full-dose regimen)
- What this could lead to
- If successful, this could show that a lower dose of betamethasone is safe for long-term brain development in preterm children, potentially reducing unnecessary steroid exposure.
- What could go wrong
- This is an observational follow-up, not a new treatment trial. The earlier BETADOSE trial did not prove the half-dose was non-inferior for breathing problems, so the lower dose may not be adopted even if neurodevelopment looks similar.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREMATURE CHILDBIRTH are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Robert Debré
RECRUITINGParis, Pa, 75019, France